ALICOSINUM
LIVE

Serial Number

97253156

Owner

Pharmaris Canada Inc.

Attorney

Nyall Engfield

First Use Date

Sep 23, 2022

Filing Date

Feb 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ALICOSINUM Trademark

Serial Number: 97253156 • Registration: 6991448

ALICOSINUM is a trademark filed by Pharmaris Canada Inc. on February 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Pharmaris Canada Inc. (19 trademarks)

Surrey BC V3W8J9 , CA

Entity Type: 03

Trademark Details

Filing Date

February 4, 2022

Registration Date

February 28, 2023

First Use Anywhere

September 23, 2022

First Use in Commerce

September 23, 2022

Published for Opposition

December 13, 2022

Goods & Services

Homeopathic pharmaceuticals for use in the treatment of flu and flu-like symptoms, namely, body aches, headaches, fever, sore throat, tiredness and chills

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Nov 10, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 4, 2022 ERRR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Oct 29, 2022 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2022 CNSA
USE AMENDMENT ACCEPTED
Oct 28, 2022 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Oct 10, 2022 AUPC
USE AMENDMENT FILED
Oct 10, 2022 IUAF
TEAS AMENDMENT OF USE RECEIVED
Oct 8, 2022 EAAU
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 3, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2022 CNSL
ASSIGNED TO EXAMINER
Sep 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2022 NWOS
NEW APPLICATION ENTERED
Feb 8, 2022 NWAP